Dr. Bryan White, MD of Hospice Reduces Dosages of Antipsychotic Medication in Dementia Patients

Avatar for Ebiz Editor
Dr Bryan White MD of Hospice Dr Bryan White MD of Hospice

Dr. Bryan White, MD has helped Hospices and medical facilities across the state of Texas institute new protocols and better their offerings to meet patients’ ever-growing needs. Recently, Dr. White instituted a dosage reduction protocol on antipsychotic medications to ensure the safety and quality care of dementia patients. 


In his career, Dr. Bryan White, MD of Hospice has worked as an internist and manager in a number of practices and has gained a reputation among his peers for enhancing care across the board. He’s witnessed the effects of high doses on patients and today seeks reform in medications for those most at risk of harmful effects. Recently, he instituted a dosage reduction protocol for antipsychotic medications, specifically in dementia patients.


To help his proposal gain traction among medical professionals in his state, Dr. Bryan White, MD of Hospice first mentioned his new dosage reduction protocol in the Texas Medical Foundation (TMF) open forum. The idea was received well by those who attended the forum and has already been implemented into many medical facilities across Texas. The TMF is instrumental in helping top healthcare professionals voice their opinions, present new ideas, and collaborate on solutions that improve care in a variety of fields. 


The mission of the Texas Medical Foundation is to promote quality healthcare through contracts

with federal, state, local governments, and private organizations, making it the ideal arena for new medical protocols. The foundation partners with healthcare providers in a variety of settings to ensure patients throughout Texas receive quality medical care.


Professionals like Dr. Bryan White, MD of Hospice have used the TMF for decades to make large-scale improvements in the medical field. It was awarded the Medicare peer review

organization contract in 1984, which allowed the group to perform reviews for Medicare beneficiaries. Since then, however, it has evolved to also include quality improvement activities in facilities such as hospitals, nursing homes, physician offices and home health agencies. The TMF has grown to offer consulting services as well, which ensures quality care at facilities throughout the state.


“It was paramount that we addressed the use of antipsychotic medications in dementia

patients––as dosage amounts didn’t always align with the need,” says Dr. Bryan White, MD of Hospice. “These medications have been found to increase mortality in patients with dementia, a large majority of whom are residents in our nursing homes. I’m proud to say we are making real

progress on this subject, and the protocol has already been successful in multiple facilities that

provide care in locked units for people who suffer from dementia.”


Dr. White graduated from the University of Texas Medical Branch School of Medicine in 1992 and has been in practice for 27 years, contributing to and improving healthcare throughout his career.